These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 1271888
1. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma. Morton DL, Eilber FR, Holmes EC, Sparks FC, Ramming K. Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888 [Abstract] [Full Text] [Related]
2. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. Eilber FR, Morton DL, Holmes EC, Sparks FC, Ramming KP. N Engl J Med; 1976 Jan 29; 294(5):237-40. PubMed ID: 1244548 [Abstract] [Full Text] [Related]
3. Adjuvant BCG immunotherapy for stage I and II malignant melanoma. Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ. Can Med Assoc J; 1983 Jun 01; 128(11):1291-5. PubMed ID: 6342739 [Abstract] [Full Text] [Related]
4. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V, Knopf B. Arch Geschwulstforsch; 1981 Jun 01; 51(6):493-6. PubMed ID: 7332442 [Abstract] [Full Text] [Related]
5. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, Sparks FC. Ann Surg; 1974 Oct 01; 180(4):635-43. PubMed ID: 4412271 [Abstract] [Full Text] [Related]
6. Immunotherapy in malignant melanomaa. Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL. Natl Cancer Inst Monogr; 1976 Nov 01; 44():85-6. PubMed ID: 799763 [Abstract] [Full Text] [Related]
7. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma. O'Connor TP, Labandter HP, Hiles RW, Bodenham DC. Br J Plast Surg; 1978 Oct 01; 31(4):317-22. PubMed ID: 361132 [Abstract] [Full Text] [Related]
17. Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial. Fisher RI, Terry WD, Hodes RJ, Rosenberg SA, Makuch R, Gordon HG, Fisher SG. Surg Clin North Am; 1981 Dec 01; 61(6):1267-77. PubMed ID: 7031934 [No Abstract] [Full Text] [Related]
18. BCG immunotherapy in patients with malignant melanoma. Karakousis CP, Douglass HO, Yeracaris PM, Holyoke ED. Arch Surg; 1976 Jun 01; 111(6):716-8. PubMed ID: 776125 [Abstract] [Full Text] [Related]
19. Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases. Morton DL, Eilber FR, Holmes EC, Ramming KP. Aust N Z J Surg; 1978 Feb 01; 48(1):49-52. PubMed ID: 276348 [Abstract] [Full Text] [Related]
20. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin. MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B. Can J Surg; 1977 Jan 01; 20(1):25-30. PubMed ID: 832200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]